From www.fda.gov - October 30, 2014 11:35 AM
The U.S. Food and Drug Administration announced today the approval of Trumenba, the first vaccine licensed in the United States to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B in individuals 10 through 25...

Via Krishan Maggon